Navigation Links
Trial Lawyer TV Ads for Medical Malpractice Lawsuits Grew 1,400 Percent in Last Four Years, Study Shows
Date:9/8/2009

WASHINGTON, Sept. 8 /PRNewswire-USNewswire/ -- Television advertisements soliciting plaintiffs for medical malpractice lawsuits increased from about 10,150 ads in 2004 to more than 156,000 ads in 2008--nearly a 1,400 percent increase in four years, according to a new study released today. The study showed that spending for these ads increased from $3.8 million to nearly $62 million during this time period--a 1,300 percent increase in 2008-adjusted dollars.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080919/USCHAMBERLOGO)

Lisa A. Rickard, president of the U.S. Chamber Institute for Legal Reform, which sponsored the study, said the finding is a window into what appears to be the growing role of medical malpractice cases in the overall litigation landscape. "Lawsuits are ultimately a business driven by the plaintiffs' bar, and when you see the marketing of medical malpractice lawsuits exploding like this, it tells you that these lawsuits are a growing sector within the larger lawsuit industry," she said.

The study was conducted by the Campaign Media Analysis Group. Evan Tracey, the firm's president and veteran advertising analyst, said, "There is no question that the number of ads airing has increased dramatically," said Tracey. "As with every other advertising sector, marketers tend to go with what is working," he said.

This new evidence of growth in plaintiffs' lawyer medical malpractice lawsuits comes amid an increased focus on medical liability reform--or lack thereof--in the larger healthcare reform debate.

In August, former Vermont Governor and Democratic National Committee Chairman Dr. Howard Dean made a telling statement when he answered a question at a Congressional town hall meeting about the lack of medical liability ref
'/>"/>

SOURCE U.S. Chamber Institute for Legal Reform
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Hard To Treat Diseases (HTDS) Completes Injection Clinical Trial
2. ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial
3. China Sky One Medical, Inc. Submits Application to Perform Clinical Trials for Two New Eye Drugs to SFDA
4. Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
5. NIAID funds clinical trials that address the problem of antimicrobial resistance
6. Key Stakeholders to Discuss Regulatory Issues Related to the Use of Study Endpoints in Multinational Clinical Trials
7. September 2009 is Atrial Fibrillation Month
8. Video: RE-LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non-valvular Atrial Fibrillation Patients
9. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
10. Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
11. CenterWatch Celebrates 15-Year Milestone as Leading Information Provider for the Clinical Trials Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... through national AAD program ,, SCHAUMBURG, ... from melanoma, the deadliest form of skin cancer, ... treated, if caught early. That,s why thousands of ... screenings in their communities through the American Academy ... The program recently reached a milestone - two ...
(Date:12/16/2009)... -- For ages, people from around the world have ... soothing waters have a reputation that dates back over ... miracles. Now, with the introduction of two bath salt ... the legendary benefits of Dead Sea salt in their ... all-natural Dead Sea salt and essential oils - but ...
(Date:12/16/2009)... International, Inc. (OTC Bulletin Board: MZEI) ... Board of Medizone New Zealand Ltd., a joint ... 50% interest, agreed on December 14, 2009 to ... International all global marketing rights of the company,s ... Marshall said, "Time has eroded the relevance of ...
(Date:12/16/2009)... While many of the,pharma companies are struggling ... and inmarket drugs, MarketsandMarkets on the other ... players. These pharma,forecasting solutions are designed for ... phase,III. These have a substantial impact on ... strategy, manufacturing planning, sales force,promotion, and planning. ...
(Date:12/16/2009)... could improve care, but privacy a concern, doctors ... U.S. physicians support the use of electronic medical ... two new studies show. , One study of ... in Massachusetts found that 86 percent believed electronic ... of care, 70 percent thought it would reduce ...
Breaking Medicine News(10 mins):Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Pros and Cons of Electronic Medical Records Weighed 2
... (NEWARK, N.J., Oct. 3,2007) Rutgers College of Nursing faculty ... of the Nurse Educator of the New York Times 2007 ... three practicing nurses and one nurse educator from hundreds of ... The winners will be featured in a special section in ...
... , WEDNESDAY, Oct. 3 (HealthDay News) -- Identifying a ... best chemotherapy for patients, U.S. research suggests. , "We ... likely to respond to standard first-line therapy and which ... second-line therapy, based on gene expression profiling," lead author ...
... The screen uses CT scans and is performed without ... new study supports the effectiveness of an innovative form ... sent through a patient,s colon. , When it ... so-called "virtual colonoscopy" is just as effective as the ...
... WEDNESDAY, Oct. 3 (HealthDay News) -- Drug-coated stents offered ... patients with blocked coronary arteries, a large Canadian study ... artery become blocked again after stent implant -- was ... getting drug-coated stents, 7.4 percent versus 10.7 percent. The ...
... WHNN radio personality,Bob Hughes, a well-known voice in the Saginaw ... is moving to Saginaw this,month. "My hearing became damaged ... the quality of my life has changed significantly since being,fitted ... Hearing,",says Hughes. "I am really enjoying my new ears." ...
... UNION CITY, Calif., Oct. 3 Abaxis, Inc.,(Nasdaq: ... point-of-care,blood chemistry analysis systems, announced today the launch ... conjunction with the Piccolo xpress(TM) point of,care analyzer. ... specifically for imaging and,radiology centers in the United ...
Other Medicine News:Health News:Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award 2Health News:Gene Tests Match Up Lung Tumors, Best Treatment 2Health News:'Virtual' Colonoscopy an Effective Option: Study 2Health News:'Virtual' Colonoscopy an Effective Option: Study 3Health News:Study Finds Benefits With Drug-Coated Stents 2Health News:Study Finds Benefits With Drug-Coated Stents 3Health News:WHNN's Bob Hughes Fitted With Hearing Aids by Mobile Care Hearing Clinic Now Serving Saginaw Area 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 3
(Date:12/16/2009)... 16 Optimer Pharmaceuticals, Inc. (Nasdaq: ... 28th Annual J.P. Morgan Healthcare Conference at the ... Wednesday, January 13, 2010. Michael N. Chang, Optimer,s ... 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time). ... audio webcast of this presentation will be accessible ...
(Date:12/16/2009)... 16 , ... Microplasmin Recruits a Total of Over,640 patients ... ThromboGenics NV (Euronext Brussels: THR), a ... of innovative treatments for eye,disease, vascular disease ... completed,the enrolment of the second Phase III ...
(Date:12/15/2009)... Inc., a global leader focused on improving blood collection, ... to provide blood centers with Alyx® system supplies needed ... filed yesterday against Fenwal by Haemonetics Corporation ( HAE). ... an advanced medical instrument used worldwide to collect two ... about 30 minutes. ,, Fenwal will ask ...
Breaking Medicine Technology:Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 3Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 1Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 2Syphilis survey reveals need for accurate testing for early infection 59960 1RIT scientist shines laser light on methane in pursuit of clean fuel 10490 1RIT scientist shines laser light on methane in pursuit of clean fuel 10490 2
... Computerized tomographic (CT),colonography, also known as virtual colonoscopy, ... flexible tube with a camera to view the,lining ... detect cancer and,precancerous polyps and could serve as ... the results of the American College of,Radiology Imaging ...
... Biotech has become,aware of preliminary data from an ... in patients with acute ischemic stroke. In,this study, ... with,Epoetin alfa within six hours of the onset ... placebo. Ortho Biotech has reported this,information to the ...
Other Medicine Technology:Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 2Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 3Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: